Filing Flows › Comparisons › TECH vs VIR
Bio-Techne vs Vir Biotechnology: TECH and VIR compared
Bio-Techne is the larger company: $300M of revenue in its latest quarter (Q1 FY27) against $239M for Vir Biotechnology (Q2 2026). Vir Biotechnology is growing faster (197× against +5% a year earlier). Vir Biotechnology is more profitable, with an operating margin of 30.7% against 12.2%.
Where the money goes: TECH and VIR
Bio-Techne (TECH) · Q1 FY27
Bio-Techne, Q1 FY27: revenue $300M (+5% year over year), operating margin 12.2%, net earnings $28.3M, operating cash flow $73.1M. The chart follows the revenue to costs, profit and cash.
Vir Biotechnology (VIR) · Q2 2026
Vir Biotechnology, Q2 2026: revenue $239M (197× year over year), operating margin 30.7%, net earnings $80.1M, operating cash flow $123M. The chart follows the revenue to costs, profit and cash.
| Bio-Techne (TECH) | Vir Biotechnology (VIR) | |
|---|---|---|
| Latest quarter | Q1 FY27 | Q2 2026 |
| Revenue | $300M | $239M |
| Revenue growth, Y/Y | +5% | 197× |
| Gross margin | 65.6% | — |
| Operating margin | 12.2% | 30.7% |
| Net earnings | $28.3M | $80.1M |
| Net margin | 9.4% | 33.5% |
| Operating cash flow | $73.1M | $123M |
| Free cash flow | $67.2M | $123M |
| Market value | $11.4B | — |
| P/E | 62.9× | — |
| Analysts’ mean target | $70.50 | — |
Where the revenue comes from
Bio-Techne
- Product and Services: $285M (95%)
- Royalty: $14.5M (5%)
Vir Biotechnology
- License and collaboration revenue: $239M (100%)
- Grant revenue: $11K (0%)
Questions
Which is bigger, Bio-Techne or Vir Biotechnology?
Bio-Techne is the larger company: $300M of revenue in its latest quarter (Q1 FY27) against $239M for Vir Biotechnology (Q2 2026).
Is Bio-Techne or Vir Biotechnology growing faster?
Vir Biotechnology is growing faster (197× against +5% a year earlier).
Which is more profitable, Bio-Techne or Vir Biotechnology?
Vir Biotechnology is more profitable, with an operating margin of 30.7% against 12.2%.
More: Bio-Techne earnings · how Bio-Techne makes money · Vir Biotechnology earnings · how Vir Biotechnology makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 6, 2026; 10-Q filed Aug 5, 2026). Fiscal quarters can end on different dates. Not investment advice.